Anuloma Viloma TimerIn January 2026, a clinical trial completed at Istanbul Medipol University Hospital did something that the pranayama literature has been quietly waiting for. It did not test pranayama against a control. It tested two kinds of pranayama against each other.
The trial was registered as NCT07320742, “Fast vs. Slow Pranayama for Breathing, Heart, Balance, and Well-Being in Students.” Two arms, two clearly defined practice protocols, one population. Slow pranayama, which in this study included Nadishodhana (the Sanskrit name for alternate nostril breathing) and Savitri pranayama, was assigned to one group. Fast pranayama, the Bhastrika and Kapalbhati family, was assigned to the other. Both arms practised. Both arms were measured before and after.
The finding worth pinning to a wall is this. Heart rate dropped significantly in the slow group. Diastolic blood pressure dropped significantly in the slow group. Rate-pressure product, which is the product of systolic pressure and heart rate and an accepted proxy for cardiac workload, dropped significantly in the slow group. Double product, a similar workload measure, dropped significantly in the slow group. In the fast pranayama group, those cardiovascular markers did not move in the same direction or to the same degree. Both groups reported lower perceived stress. Only one group produced the heart-side numbers.
That is not a subtle distinction. The wellness market tends to use “breathwork” as if it referred to a single intervention. The Istanbul finding is the opposite of that. It says that the speed of the breath, specifically, is what carries the cardiovascular effect. Fast forced breathing did not produce the same heart-rate and pressure outcomes that slow rhythmic alternating breathing did. They are different drugs, in the pharmacological sense, even though they share a category name.
For anyone who has been practising Anuloma Viloma, this is not a surprise. The pace of the practice has always been the point. The original instruction is slow. The traditional ratios (4 in, 16 hold, 8 out, or whichever ratio your teacher hands you) are slow. The held pause, kumbhaka, is what stretches the cycle long enough for the parasympathetic system to take the wheel. Speed it up and you get something else entirely. You may still get a stress-reduction signal, because the act of practising in itself is calming. But you will not get the heart-rate drop the slow version delivers.
This is the kind of evidence the app exists to make easier to use. The Anuloma Viloma Timer is a slow-pranayama tool by design. It guides the inhale, the side switch, the held pause, and the exhale at speeds that fit the slow protocols a trial like the Istanbul one validates. There is no fast-pranayama mode. There is no Kapalbhati timer hidden behind a paywall. The cadence is the part that produced the cardiovascular numbers in the study, and the cadence is what the app is built around.
A note on what this study did not test, because it matters. NCT07320742 was conducted on students. Students are young, generally healthy, and not the population that most blood-pressure intervention studies enrol. The fact that heart rate and diastolic pressure moved in a young healthy group, where there is less room to move them, suggests that the effect in older or hypertensive populations would likely be larger. That is consistent with the wider pranayama literature. A 2025 meta-analysis published in Frontiers in Psychiatry already showed pranayama producing meaningful changes in anxiety, depression, and stress measures across clinical populations. A 2026 review of 683 patients found slow-paced pranayama lowered blood pressure across hypertensive cohorts. Istanbul adds a piece the others did not have, which is a head-to-head comparison between slow and fast.
There is a strategic point too. Most people who reach for a breathing practice today do so because of a stress moment. A racing pulse before a meeting, a 3 a.m. waking with the heart pounding, an argument that has not finished arguing in the body. The cardiovascular system is the part that complains first. A trial that shows slow pranayama specifically calms the cardiovascular system, where the fast variant does not, makes it easier to choose the right tool for the moment. If the goal is to bring the heart back down, the protocol is slow. If the goal is to wake the system up before a workout, the protocol is fast. They are not interchangeable.
June is Men’s Health Month in the United States. The campaign closes on June 30. Hypertension, defined as systolic above 130 or diastolic above 80, is the most common cardiovascular condition in men over forty. The Istanbul study suggests a free, drug-free, equipment-free practice that lowers diastolic pressure in a young population is probably worth a serious trial in an older one. The mechanism is plausible. The cost is zero. The barrier is the cadence, which is precisely what a timer is for.
If you would like to try the protocol that the Istanbul researchers tested, the practice they assigned the slow group is the same one this app is built around. Five to ten minutes a day, slow nasal breathing alternating between the nostrils, with the timer doing the counting so the breath can stop being a thing you have to manage and start being a thing you can rest into.
Anuloma Viloma Timer is free on the App Store. No subscription necessary.